Clinical Trial Update: Intravenous Lidocaine in the Prevention of Postoperative Vomiting in Elective Tonsil Surgery [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating intravenous lidocaine to prevent postoperative nausea and vomiting after elective tonsil surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain
• Postoperative Nausea and Vomiting

Drugs mentioned

• Lidocaine (intravenous) (lidocaine)

Snippet

Sponsor: Pontificia Universidad Catolica de Chile | Conditions: Postoperative Nausea and Vomiting, Pain | Phase 4 | Status: COMPLETED